Search research articles
Contact Us
Filters
Showing results (171-180 of 209) with videos related to
Page
of 21
Sort By:
European Urology
|
August 5, 2015
Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
Elizabeth R Plimack, Roland L Dunbrack, Timothy A Brennan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 10, 2010
NCCN clinical practice guidelines in oncology: prostate cancer
James Mohler, Robert R Bahnson, Barry Boston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2016
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
Toni K Choueiri, Mayer N Fishman, Bernard Escudier, et al.
The New England Journal of Medicine
|
September 26, 2015
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J Motzer, Bernard Escudier, David F McDermott, et al.
Cancer Discovery
|
February 24, 2025
Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
Miya B Hugaboom, Lena V Wirth, Kelly Street, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 14, 2013
Penile cancer: Clinical Practice Guidelines in Oncology
Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
Journal for Immunotherapy of Cancer
|
July 15, 2020
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial
Robert J Motzer, Bernard Escudier, David F McDermott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 10, 2017
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2023
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
H Josh Jang, Galen Hostetter, Alexander W Macfarlane, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 16, 2013
Bladder cancer
Peter E Clark, Neeraj Agarwal, Matthew C Biagioli, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 209) with videos related to
Sort By:
Page
of 21
European Urology
|
August 5, 2015
Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
Elizabeth R Plimack, Roland L Dunbrack, Timothy A Brennan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 10, 2010
NCCN clinical practice guidelines in oncology: prostate cancer
James Mohler, Robert R Bahnson, Barry Boston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2016
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
Toni K Choueiri, Mayer N Fishman, Bernard Escudier, et al.
The New England Journal of Medicine
|
September 26, 2015
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J Motzer, Bernard Escudier, David F McDermott, et al.
Cancer Discovery
|
February 24, 2025
Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma
Miya B Hugaboom, Lena V Wirth, Kelly Street, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 14, 2013
Penile cancer: Clinical Practice Guidelines in Oncology
Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
Journal for Immunotherapy of Cancer
|
July 15, 2020
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial
Robert J Motzer, Bernard Escudier, David F McDermott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 10, 2017
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2023
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
H Josh Jang, Galen Hostetter, Alexander W Macfarlane, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 16, 2013
Bladder cancer
Peter E Clark, Neeraj Agarwal, Matthew C Biagioli, et al.
Page
of 21